User menu

Differential induction of midazolam metabolism in the small intestine and liver by oral and intravenous dexamethasone pretreatment in rat.

Bibliographic reference Eeckhoudt, S L ; Horsmans, Yves ; Verbeeck, Roger-K.. Differential induction of midazolam metabolism in the small intestine and liver by oral and intravenous dexamethasone pretreatment in rat.. In: Xenobiotica; the fate of foreign compounds in biological systems, Vol. 32, no. 11, p. 975-84 (2002)
Permanent URL http://hdl.handle.net/2078.1/23997
  1. Chung Woon-Gye, Roh Hyung-Keun, Kim Hwan-Mook, Cha Young-Nam, Involvement of CYP3A1, 2B1, and 2E1 in C-8 hydroxylation and CYP 1A2 and flavin-containing monooxygenase in N-demethylation of caffeine: identified by using inducer treated rat liver microsomes that are characterized with testosterone metabolic patterns, 10.1016/s0009-2797(97)00109-9
  2. Eeckhoudt Stéphane L, Desager Jean-Pierre, Horsmans Yves, De Winne Ann J, Verbeeck Roger K, Sensitive assay for midazolam and its metabolite 1′-hydroxymidazolam in human plasma by capillary high-performance liquid chromatography, 10.1016/s0378-4347(98)00137-6
  3. Christopher Gorski J., Hall Stephen D., Jones David R., VandenBranden Mark, Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily, 10.1016/0006-2952(94)90543-6
  4. Gushchin Ghennady V., Gushchin Marina I., Gerber Nicholas, Boyd R.Thomas, A Novel Cytochrome P450 3A Isoenzyme in Rat Intestinal Microsomes, 10.1006/bbrc.1999.0200
  5. HIGASHIKAWA FUMIKO, MURAKAMI TERUO, KANEDA TATSUYA, TAKANO MIKIHISA, In-vivo and In-vitro Metabolic Clearance of Midazolam, a Cytochrome P450 3A Substrate, by the Liver under Normal and Increased Enzyme Activity in Rats, 10.1211/0022357991772600
  6. Kaminsky Laurence S., Fasco Michael J., Small Intestinal Cytochromes P450, 10.3109/10408449209089881
  7. Keelan M., Doring K., Tavernini M., Wierzbicki E., Clandinin M. T., Thomson A. B. R., Dietary ω3 fatty acids and cholesterol modify enterocyte microsomal membrane phospholipids, cholesterol content and phospholipid enzyme activities in diabetic rats, 10.1007/bf02536253
  8. Krishna Devarakonda R., Klotz Ulrich, Extrahepatic Metabolism of Drugs in Humans : , 10.2165/00003088-199426020-00007
  9. LOWRY O. H., Journal of Biological Chemistry, 193, 265 (1951)
  10. Lu A. Y., Pharmacology Reviews, 31, 277 (1979)
  11. PORTER T. D., Journal of Biological Chemistry, 266, 13469 (1991)
  12. Rendic Slobodan, Carlo Frederick J. Di, Human Cytochrome P450 Enzymes: A Status Report Summarizing Their Reactions, Substrates, Inducers, and Inhibitors, 10.3109/03602539709037591
  13. Thummel K. E., Wilkinson G. R., IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3A, 10.1146/annurev.pharmtox.38.1.389
  14. Watanabe Minoru, Tateishi Tomonori, Asoh Masako, Nakura Hironori, Tanaka Masami, Kumai Toshio, Kobayashi Shinichi, Effects of glucocorticoids on pharmacokinetics and pharmacodynamics of midazolam in rats, 10.1016/s0024-3205(98)00440-8
  15. Watkins P B, Wrighton S A, Schuetz E G, Molowa D T, Guzelian P S, Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man., 10.1172/jci113156
  16. WONG S. G., Drug Metabolism and Disposition, 27, 960 (1999)
  17. Wu Chi-Yuan, Benet Leslie Z., Hebert Mary F., Gupta Suneel K., Rowland Malcolm, Gomez Denise Y., Wacher Vincent J., Differentiation of absorption and first-pass gut and hepatic metabolism in humans: Studies with cyclosporine*, 10.1016/0009-9236(95)90168-x
  18. ZHANG Q.-Y., Drug Metabolism and Disposition, 24, 322 (1996)